North America Hydrocephalus Shunts Market Key Players Analysis, Opportunities and Growth Forecast to 2028
According to Business Market Insights’ research, the North America Hydrocephalus Shunts Market was valued at US$ 122.61 million in 2022 and is expected to reach US$ 150.64 million by 2028, registering a CAGR of 3.5% from 2022 to 2028. Increasing prevalence of hydrocephalus and increasing advancement in hydrocephalus valves are the critical factors attributed to the market expansion.
Download Sample PDF Copy: https://www.businessmarketinsights.com/sample/BMIRE00027769
The List of Companies
- B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG)
- HpBio Próteses, inc.
- Integra LifeSciences Holdings Corporation
- KANEKA MEDIX CORP.
- Medtronic
- Natus Medical Incorporated
- Sophysa
- Spiegelberg GmbH & Co. KG
Cerebrospinal fluid (CSF) plays a crucial role in protecting the brain and spinal cord from injuries and infections. However, excessive accumulation of CSF in brain cavities can increase intracranial pressure, leading to hydrocephalus. This condition may result in macrocephaly and cognitive impairments. Hydrocephalus is more commonly observed in infants and children, as well as in individuals aged 60 and above. According to the Hydrocephalus Association, more than 1 million Americans are affected by this condition, with an incidence rate of 1 in every 770 newborns in the US.
The primary treatment for hydrocephalus involves managing CSF levels using shunt systems. These medical devices help drain excess CSF from the brain and redirect it to other parts of the body, where it is absorbed into the circulatory system. As a result, the high prevalence of hydrocephalus is driving demand for hydrocephalus shunts, thereby fueling market growth in North America.
Market Overview
The North American hydrocephalus shunts market is segmented into the US, Canada, and Mexico, with the US being the leading contributor. Market growth in the region is primarily driven by rising neurological disease cases, increasing health concerns, and the presence of a well-developed healthcare infrastructure. According to the Hydrocephalus Organization, hydrocephalus affects 1 in 770 newborns and 1 in 100 senior citizens in the US. Additionally, significant investments in neurosurgical device research and development by key medical companies aim to reduce the socioeconomic burden of hydrocephalus, further boosting market expansion in North America.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment